LIGAND PHARMACEUTICALS INC (LGNXZ) Revenue 2016–2025
LIGAND PHARMACEUTICALS INC (LGNXZ) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$268.1MFY2025 · since FY2016: $109.0M → $268.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $268.1M | +60.4% |
| FY2024 | $167.1M | +27.3% |
| FY2023 | $131.3M | -33.1% |
| FY2022 | $196.2M | -18.8% |
| FY2021 | $241.5M | +47.7% |
| FY2020 | $163.6M | +36.0% |
| FY2019 | $120.3M | -52.2% |
| FY2018 | $251.5M | +78.2% |
| FY2017 | $141.1M | +29.5% |
| FY2016 | $109.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice